Subjects | Asthma/control | Gender (M/F) | Age (years) | PD20 (μg) | Atopy (Y/N) | FEV1 (litres) | FEV1% predicted | FeNO50 (ppb) | Bronchial flux (nl/s) | Alveolar NO (ppb) | Fibroblasts (C/D) |
1 | Asthma | M | 38 | 122 | Y | 4.43 | 98 | 239.7 | 12.39 | 5.62 | C/D |
2 | Asthma | M | 22 | 24 | Y | 6.04 | 124 | 100.6 | 4.91 | 4.37 | C/D |
3 | Asthma | F | 23 | 5 | Y | 3.41 | 92.4 | 109.3 | 5.69 | 3.60 | C/D |
4 | Asthma | F | 31 | 16 | Y | 3.06 | 94.8 | 61.7 | 0.91 | 2.85 | C/D |
5 | Asthma | M | 24 | 78 | Y | 7.31 | 91.8 | 18.9 | 3.55 | 3.64 | D |
6 | Asthma | M | 24 | 79 | Y | 3.81 | 88 | 69.4 | 4.19 | 2.09 | D |
7 | Asthma | F | 28 | 145 | Y | 3.16 | 103 | 15.8 | 0.68 | 2.96 | D |
8 | Asthma | M | 25 | 134,5 | Y | 4.51 | 90 | ND | ND | ND | C |
9 | Asthma | M | 35 | <0.05 | Y | 2.21 | 62 | 32,2 | ND | ND | C |
10 | Asthma | F | 31 | <0.05 | Y | 3.36 | 102 | 44 | ND | ND | C |
11 | Asthma | F | 26 | 826 | Y | 4.57 | 101 | ND | ND | ND | C |
12 | Control | M | 28 | >2000 | Y | 3.98 | 108.7 | 21.20 | 1.16 | 2.34 | C/D |
13 | Control | F | 27 | >2000 | Y | 2.98 | 96.3 | 9.80 | 0.47 | 1.74 | C/D |
14 | Control | F | 37 | >2000 | Y | 3.21 | 103.8 | 15.60 | 0.56 | 3.74 | D |
15 | Control | F | 24 | >2000 | Y | 3.21 | 105 | 13.2 | 0.6 | 2.66 | C/D |
16 | Control | M | 29 | >2000 | Y | 4.69 | 114.6 | 27.7 | 1.28 | 3.0 | C/D |
17 | Control | M | 30 | >2000 | N | 5.11 | 116.4 | 17.3 | 0.89 | 2.27 | D |
18 | Control | F | 24 | >2000 | N | 3.68 | 95.4 | 9.8 | 0.44 | 2.48 | D |
19 | Control | M | 40 | >2000 | N | 4.91 | 109.8 | 8.4 | 0.38 | 2.13 | C/D |
20 | Control | M | 24 | >2000 | N | 5.38 | 113.5 | 21.10 | 1.10 | 3.70 | C/D |
21 | Control | F | 33 | >2000 | N | 3.71 | 100.7 | 16.10 | 1.02 | 2.02 | C/D |
22 | Control | F | 22 | >2000 | N | 2.38 | 95.1 | 8.90 | 0.70 | 1.68 | D |
23 | Control | F | 23 | >2000 | N | 3.25 | 84.1 | 16.60 | 0.75 | 2.10 | D |
C, successful recovery of central fibroblasts; D, successful recovery of distal fibroblasts; F, female; FeNO50, exhaled NO at 50 ml/s; FEV1, forced expiratory volume in 1 s; M, male; N, no; ND, not done; NO, nitric oxide; PD20, metacholine responsiveness (2000 μg represents the threshold); Y, yes.